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GENERAL PROCEDURE
All commercially available reagents were purchased and used without further purification, unless otherwise stated. Commercially available solvents (> 99.0% purity) were used for column chromatography without any further purification. Proton and carbon NMR spectra were recorded on a 400 MHz spectrometer. ) and are partially reported. Analytical thin-layer chromatography (TLC) was performed using Silica Gel 60 Å F254 precoated plates (0.25 mm thickness). The following visualization methods were used for monitoring reactions and column chromatography: UV absorption by fluorescence quenching; Ninhydrin spray (Ninhydrin: acetic acid: nbutanol/ 0.6g: 6mL: 200mL) or PMA stain (phosphomolybdic acid, H 2 SO 4 ). Flash column chromatography was performed using Flash Silica Gel (32-63 micron). Mass spectrometry data were collected on a UPLC/MS instrument equipped with a reverse-phase C18 column (1.7 µm particle size, 2.1 x 50 mm), dual atmospheric pressure chemical ionization (API)/electrospray (ESI) mass spectrometry detector, and photodiode array detector.
GENERAL PROCEDURE FOR THE SYNTHESIS OF BENZIMIDAZOLE ANALOGS
To a solution of commercially available carboxylic acid (1.0 equiv) in 30 mL of toluene or DMF was added N-ethyldiisopropylamine (1.9 equiv) and the solution was stirred for 10 min at room temperature. To the stirring solution, HBTU (2 equiv) was added and the reaction mixture stirred for another 10 min. To the stirring reaction mixture, O-phenylenediamine (1 equiv) was added and stirred for 3-4 hours. Thereafter, the reaction was heated under reflux for 3 hours. The reaction was cooled to room temperature, after which the solvent was removed in vacuo in the case of toluene, but for DMF, the reaction mixture was diluted with water and products were extracted using ethyl acetate (EtOAc). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude product was purified using column chromatography using hexanes/EtOAc in an increasing polarity up to 1:1 mixture. The fractions containing the desired product were concentrated and recrystallized in hexanes/EtOAc (1:1) to yield the product as a white solid. All the compounds were characterized by 1D ( 
2-phenethyl-1H-benzo[d]imidazole (15f)
White solid, 
2-(5-methoxy-1H-indol-2-yl)-1H-benzo[d]imidazole (17a)
5-fluoro-2-(5-methoxy-1H-indol-2-yl)-1H-benzo[d]imidazole (17b)
5-bromo-2-(5-methoxy-1H-indol-2-yl)-1H-benzo[d]imidazole (17d)
2-(5-methoxy-1H-indol-2-yl)-5-methyl-1H-benzo[d]imidazole (17f)
White solid, 0.32 g, 89%; R f 0. 
Tert-butyl 1-(1H-benzo[d]imidazol-2-yl)-2-methylbutylcarbamate (19b)
Tert-butyl 1-(1H-benzo[d]imidazol-2-yl)-2-methylpropylcarbamate (19c)
White solid, 0.48 g, 94%; R f 0. 
Tert-butyl 2-(1H-benzo[d]imidazol-2-yl)pyrrolidine-1-carboxylate (19d)
Tert-butyl 1-(1H-benzo[d]imidazol-2-yl)-2-(4-(benzyloxy)phenyl) ethylcarbamate (19e)
White solid, 0.42 g, 84%; R f 0. 
Tert-butyl 1-(1H-benzo[d]imidazol-2-yl)-2-(benzyloxy) ethylcarbamate (19f)
S9
Tert-butyl 1-(1H-benzo[d]imidazol-2-yl)-3-(benzyloxy) butylcarbamate (19h)
White solid, 0.47 g, 94%; R f 0.40 (1:1/hexanes:EtOAc); IR: 3324.3, 2977.1, 1678.7, 1528.7cm 
